Can drugs cause autoimmune thrombocytopenic purpura?

Seminars in Hematology

Volumn 37, Issue 3, 2000, Pages 229-238

  Aster, Richard H ^a,b  

^a BLOOD RESEARCH INSTITUTE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; AUTOANTIBODY; CELL MEMBRANE PROTEIN; COTRIMOXAZOLE; DANAZOL; EPTIFIBATIDE; HEPARIN DERIVATIVE; IMMUNOGLOBULIN G; METHYLDOPA; PENICILLIN DERIVATIVE; PREDNISONE; PROCAINAMIDE; QUINIDINE; QUININE; SULFAMETHOXAZOLE; THROMBOCYTE ANTIBODY; TIROFIBAN; XENOBIOTIC AGENT;

ARTICLE; B LYMPHOCYTE; DRUG INDUCED DISEASE; DRUG STRUCTURE; HEART ATRIUM FIBRILLATION; HUMAN; HUMORAL IMMUNITY; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOPATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE; THROMBOCYTE MEMBRANE; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIC PURPURA; URINARY TRACT INFECTION;

EID: 0033858040     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0037-1963(00)90101-X     Document Type: Article

References (63)

1. The role of Sedormid in the immunological reaction that results in platelet lysis in Sedormid purpura
2. Gold-induced thrombocytopenia: 12 cases and a review of the literature
3. Response of thrombocytes to toxic injury
4. Drug-induced immune thrombocytopenia: An overview of pathogenesis
5. Viruses: Hidden self-epitopes and autoimmunity
6. Anti-cytochrome P450 autoantibodies in drug-induced disease
7. Pharmacokinetics - The dynamics of drug absorption, distribution, and elimination
8. Plasma autoantibodies against platelet glycoprotein IIb/IIIa from patients with autoimmune thrombocytopenic purpura may recognize different antigenic determinants
9. Autoantibodies against platelet glycoproteins in autoimmune thrombocytopenic purpura: Their clinical significance and response to treatment
10. A glucuronide acid conjugate of naproxen as a cause of drug-induced immune thrombocytopenia
11. Sensitivity to a metabolite of diclofenac as a cause of acute immune hemolytic anemia
12. Characterization of the binding domains on platelet glycoproteins Ib-IX and IIb/IIIa complexes for quinine/quinidine-dependent antibodies
13. Fab-mediated binding of drug-dependent antibodies to platelets in quinidine- and quinine-induced thrombocytopenia
14. Protein haptenation by drugs
15. Antibodies associated with sulfonamide-induced immune thrombocytopenia react preferentially with calcium-dependent epitopes on the glycoprotein IIb/IIIa complex
16. Recombinant human natural autoantibodies against GPIIb/IIIa inhibit binding of autoantibodies from patients with AITP
17. Recombinant anti-GPIIb/IIIa autoantibodies from different normal donors share high homology
18. Autoreactive T cells in healthy individuals show tolerance in vitro with characteristics similar to but distinct from clonal allergy
19. Autoimmunity. What is the turning point?
20. Platelet-associated antibody to glycoprotein IIb/IIIa from chronic immune thrombocytopenic purpura patients often binds to divalent cation-dependent antigens
21. Target antigens for red-cell-bound autoantibodies
22. Immune cytopenia associated with antibiotics
23. Idiopathic thrombocytopenic purpura: A concise summary of the pathophysiology and the diagnosis in children and adults
24. Viruses, cytokines, antigens, and autoimmunity
25. Metal ion induced autoimmunity
26. Alteration of a model antigen by Au (III) leads to T cell sensitization to cryptic peptides
27. Polymorphic human cytochrome P450 enzymes: An opportunity for individualized drug treatment
28. Metabolic basis for a drug hypersensitivity: Antibodies in sera from patients with halothane hepatitis recognize liver neoantigens that contain the trifluoroacetyl group derived from halothane
29. Platelet autoantibodies (IgG, IgM, IgA) against glycoproteins IIb/IIIa and Ib/IX in patients with thrombocytopenia
30. Platelet-associated anti-glycoprotein (GP) IIb/IIIa autoantibodies in chronic immune thrombocytopenic purpura mainly recognize cation-dependent confirmations: Comparison with the epitopes of serum autoantibodies
31. Autoreactive T cells to platelet GPIIb/IIIa in immune thrombocytopenic purpura. Role in production of anti-platelet autoantibody
32. How can cryptic epitopes trigger autoimmunity?
33. Drug-dependent and non-drug-dependent antiplatelet antibody in drug-induced immunologic thrombocytopenic purpura
34. Idiopathic thrombocytopenic purpura in children
35. Metabolites and allergic drug reactions
36. Quinidine-induced thrombocytopenic purpura: Clinical presentation in relation to drug-dependent and drug-independent platelet antibodies
37. Drug-protein conjugation and its immunological consequences
38. Drug-induced autoimmune hemolytic anemia
39. The immunologic and metabolic basis of drug hypersensitivities
40. Drug-induced thrombocytopenia
41. Red cell and platelet-bound IgG penicillin antibodies in a patient with thrombocytopenia
42. Dominance and crypticity of T cell antigenic determinants
43. Autoimmunity
44. Immune focusing vs diversification and their connection to immune regulation
45. Mechanisms of drug-induced immunologically mediated cytopenias
46. Binding of quinine- and quinidine-dependent drug antibodies to platelets is mediated by Fab domain of the immunoglobulin G and is not Fc dependent
47. Drug-induced immune neutropenia
48. Idiopathic (autoimmune) thrombocytopenic purpura with a complement-fixing autoantibody and response to plasma exchange
49. The functional significance of epitope spreading and its regulation by co-stimulatory molecules
50. Molecular basis of drug-induced immunological liver injury
51. Thrombocytopenia due to quinidine or quinine
52. Characteristics of quinine- and quinidine-induced antibodies specific for platelet glycoproteins IIb and IIIa
53. Detection of drug-dependent, platelet-reactive antibodies by antigen capture ELISA and flow cytometry
54. Thrombocytopenia associated with gold therapy: A drug-induced autoimmune disease?
55. Presentation of non-peptide antigens, in particular drugs, to specific T cells
56. Current concepts in the treatment of immune thrombocytopenia
57. The antibody response in rabbits to previously tolerated antigens
58. Studies on the reactivity of acyl glucuronides. VI. Modulation of reversible and covalent interaction ofdiflunisal acyl glucuronide and its isomers with human plasma protein in vitro
59. Immune drug-induced hemolytic anemias
60. Genetic polymorphisms of human N-acetylase, cytochrome P450, glutathione-S-transferase, and epoxide hydrolase: Relevance to xenobiotic metabolism and toxicity
61. Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein
62. Bioactivity by glucuronide-conjugate formation
63. Hypersensitivity to nonsteroidal antiinflammatory drugs